Flerie
NET ASSET VALUE – 28 February 2025
MARKN.
On the 28 February 2025 Flerie AB's Net Asset Value (NAV) was SEK 4,063 million and NAV per share was SEK 52.05.
Allocation of NAV | Share of portfolio company | Fair value (MSEK) | Part of NAV per share (SEK) | Share of NAV |
| Product Development | ||||
| Prokarium | 42% | 476 | 6.09 | 11.7% |
| Xspray Pharma | 18% | 209 | 2.68 | 5.2% |
| Empros Pharma | 79% | 204 | 2.62 | 5.0% |
| KAHR Medical | 31% | 203 | 2.60 | 5.0% |
| Lipum | 57% | 196 | 2.51 | 4.8% |
| Atrogi | 37% | 176 | 2.25 | 4.3% |
| Xintela | 61% | 162 | 2.08 | 4.0% |
| Microbiotica | 10% | 135 | 1.73 | 3.3% |
| Geneos Therapeutics | 12% | 103 | 1.32 | 2.5% |
| Mendus | 24% | 95 | 1.21 | 2.3% |
| AnaCardio | 14% | 69 | 0.89 | 1.7% |
| Toleranzia | 66% | 67 | 0.86 | 1.6% |
| EpiEndo Pharmaceuticals | 9% | 55 | 0.71 | 1.4% |
| Synerkine Pharma | 43% | 55 | 0.71 | 1.4% |
| Vitara Biomedical | 10% | 54 | 0.69 | 1.3% |
| Egetis Therapeutics | 2% | 29 | 0.37 | 0.7% |
| Buzzard Pharmaceuticals | 14% | 29 | 0.37 | 0.7% |
| Sixera Pharma | 24% | 27 | 0.35 | 0.7% |
| Alder Therapeutics | 21% | 17 | 0.22 | 0.4% |
| Amarna Therapeutics | 58% | 11 | 0.15 | 0.3% |
| Strike Pharma | 16% | 9 | 0.11 | 0.2% |
| Total | 2,383 | 30.53 | 58.6% | |
| Commercial Growth | ||||
| NorthX Biologics | 92% | 189 | 2.42 | 4.7% |
| Symcel | 31% | 174 | 2.23 | 4.3% |
| Chromafora | 31% | 73 | 0.93 | 1.8% |
| Nanologica | 43% | 72 | 0.92 | 1.8% |
| A3P Biomedical | 8% | 46 | 0.59 | 1.1% |
| Frontier Biosolutions | 2% | 19 | 0.24 | 0.5% |
| Bohus Biotech | 45% | 17 | 0.21 | 0.4% |
| Provell Pharmaceuticals* | 72% | 0 | 0.00 | 0.0% |
| Total | 589 | 7.54 | 14.5% | |
| Limited Partnerships, total | 85 | 1.08 | 2.1% | |
| Assets related to Portfolio companies | 245 | 3.14 | 6.0% | |
| Other assets and liabilities | 761 | 9.75 | 18.7% | |
| Net asset value | 4,063 | 52.05 | 100.0% | |
* indirect shares in Provell Pharmaceuticals
| Datum | 2025-03-05, kl 08:00 |
| Källa | MFN |
Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet